- Investing Ideas
- Danish Pharmaceuticals & Biotech Potentially Undervalued Companies
Danish Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
5
Companies with a Value score of at least 3, ordered by Value score
5 companies
Bavarian Nordic
Market Cap: DKK 16.5b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 214.20
7D
10.8%
1Y
-9.6%
H. Lundbeck
Market Cap: DKK 42.2b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 41.76
7D
-1.6%
1Y
3.0%
Novo Nordisk
Market Cap: DKK 1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 306.95
7D
2.5%
1Y
-13.9%
H. Lundbeck
Market Cap: DKK 42.2b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN A
DKK 41.55
7D
-1.0%
1Y
23.5%
Strategic Partners
Market Cap: DKK 30.9m
Does not have significant operations.
STRAP
DKK 695.00
7D
0.7%
1Y
-33.2%